# Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

> **NCT00560235** · PHASE1,PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 138 (actual)

## Conditions studied

- Ewing's Sarcoma Family of Tumors

## Interventions

- **DRUG:** CP-751,871

## Key facts

- **NCT ID:** NCT00560235
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** 2012-10
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560235, "Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00560235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*